Sign Up Today and Learn More About Circle Pharma Stock
Invest in or calculate the value of your shares in Circle Pharma or other pre-IPO companies through EquityZen's platform.
Circle Pharma Stock
Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.
About Circle Pharma Stock
Founded
2012
Headquarters
San Francisco, CA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Circle Pharma Press Mentions
Stay in the know about the latest news on Circle Pharma
Circle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle Therapies
businesswire • Sep 03, 2024
Alliance of Chief Executives on LinkedIn: Circle Pharma raises $54M as part of Series D while macrocycles heat up
linkedin • Aug 02, 2024
Circle Pharma files first Investigational New Drug application for first-in-class oral cyclin A/B RxL inhibitor for treatment of advanced solid tumors
businesswire • Aug 02, 2024
Circle Pharma raises $54M as part of Series D while macrocycles heat up
endpts • Jul 08, 2024
Circle Pharma files IND application for first-in-class cyclin A/B RxL inhibitor for solid tumors
bioworld • Jul 04, 2024
Circle Pharma Management
Leadership team at Circle Pharma
Board Member
Thilo Schroeder
Board Member
Peter Svennilson
Join now and verify your accreditation status to gain access to:
- Circle Pharma current valuation
- Circle Pharma stock price
- Available deals in Circle Pharma and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Circle Pharma stock?
Accredited investors can buy pre-IPO stock in companies like Circle Pharma through EquityZen funds. These investments are made available by existing Circle Pharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Circle Pharma stock?
Shareholders can sell their Circle Pharma stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
